Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avidity Biosciences Inc (NQ: RNA )

39.64 -0.32 (-0.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,730,733
Open 39.95
Bid (Size) 38.30 (1)
Ask (Size) 41.00 (2)
Prev. Close 39.96
Today's Range 38.76 - 42.00
52wk Range 4.825 - 42.00
Shares Outstanding 54,462,518
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Chart Of The Day: Avidity Biosciences - Something's Up?
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. 
Via Talk Markets
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
Via Benzinga

Performance

YTD
+332.75%
+332.75%
1 Month
+34.33%
+34.33%
3 Month
+62.33%
+62.33%
6 Month
+358.27%
+358.27%
1 Year
+217.63%
+217.63%

More News

Read More
Crude Oil Moves Higher; Vera Bradley Shares Slide
Via Benzinga
Exposures Fossil Fuels
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
Via Benzinga
Navigating 7 Analyst Ratings For Avidity Biosciences
Via Benzinga
Where Avidity Biosciences Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
Via Benzinga
Why Avidity Biosciences Shares Are Trading Higher Wednesday
Via Benzinga
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
A Closer Look at 5 Analyst Recommendations For Avidity Biosciences
Via Benzinga
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A High Point
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
2 Potentially High-Reward Growth Stocks to Buy Right Now
Via The Motley Fool
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Via InvestorPlace
RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Via Benzinga
Topics ETFs
This Demand Zone In S&P 500 Needs To Hold
Via Talk Markets
Topics Stocks
Exposures US Equities
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Via Benzinga
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
Via Benzinga
Top 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy
Via Investor's Business Daily
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.